未标题-32.jpg
+
  • 未标题-32.jpg

Moxifloxacin Hydrochloride Eye Drops

Belongs to Category:

The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.

Product Description

Approval Number:

H20234193

Indications:

For the treatment of bacterial conjunctivitis caused by the following sensitive microorganisms:

Gram-positive bacteria:

Corynebacterium spp.*

Micrococcus luteus*

Staphylococcus aureus

Staphylococcus epidermidis

Staphylococcus haemolyticus

Staphylococcus hominis

Staphylococcus warneri*

Streptococcus pneumoniae

Viridans streptococci group

Gram-negative bacteria:

Acinetobacter lwoffii*

Haemophilus influenzae

Haemophilus parainfluenzae*

Acinetobacter baumannii

Acinetobacter junii*

Stenotrophomonas maltophilia*

Chryseobacterium spp.*

Other microorganisms:

Chlamydia trachomatis
*Studies on the efficacy against these microorganisms included fewer than 10 cases.

Administration:

Instill 1 drop into the affected eye 3 times daily for 7 consecutive days.

Specifications:

0.5% (3ml:15mg)

0.5% (5ml:25mg)

 

The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.

The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.

Online Message

We will contact you within one business day. Please pay attention to your email.

Submit

Email: marcos.yuan@wangao.com.cn

Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province

 

Wangao Pharmaceutical

Mobile Version QR Code

Wangao Pharmaceutical

WeChat Official Account


Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.

Business License